Skip to main content

Day: March 7, 2022

Battalion Oil Corporation Announces Fourth Quarter and Full Year 2021 Financial and Operating Results

HOUSTON, March 07, 2022 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the fourth quarter and full year 2021. Key HighlightsReported average daily production of 17,283 Boepd and 16,241 Boepd in fourth quarter and full year 2021, respectively Proved reserves of 95.9 MMBoe, a 51% increase over year-end 2020 reserves Completed strategic refinancing in November 2021; enhanced liquidity profile allows for significant increase in activity Kicked off 2022 capital program in December 2021 with 3 well-pad at Monument Draw; expect to keep one rig running through 2022 Maintaining flat production in 2022 while driving double digit growth in daily oil production by year end 2022Management Comments Richard Little, the Company’s CEO, commented,...

Continue reading

BlueOne Card Inc. Announces Receipt of a Two Million Dollar Purchase Order from Agency Tribal Nations Federal Land Management of Mendocino Indian Reservation

The initial purchase is for 100,000 BlueOne Prepaid MasterCards LOS ANGELES, March 07, 2022 (GLOBE NEWSWIRE) — BlueOne Card, Inc. (“BlueOne Card”, “Company”) (OTC Pink: BCRD), announces receipt of a new purchase order from Agency Tribal Nations Federal Land Management of Mendocino Indian Reservation for 100,000 BlueOne Prepaid MasterCards. This initial purchase is valued at $2,000,000.00. Agency Tribal Nations has indicated an intent to purchase an additional 200,000 prepaid MasterCards raising their total to 300,000 BlueOne Prepaid MasterCards. Each new BlueOne Prepaid MasterCard carries a monthly service fee of $20.00. Other service fees may apply. Based on 100,000 cards, the Company anticipates projected annual revenues of $24,000,000 from recurring monthly fees over the first year. First year revenues for 300,000 BlueOne Prepaid...

Continue reading

Hudson Global to Report Fourth Quarter and Full Year 2021 Financial Results on March 11

Schedules Conference Call and Webcast OLD GREENWICH, CT, March 07, 2022 (GLOBE NEWSWIRE) — Hudson Global, Inc. (Nasdaq: HSON), a leading global talent solutions company, will issue fourth quarter and full year 2021 financial results for the period ended December 31, 2021, before the market opens on Friday, March 11, 2022. The company will host a conference call to review its results that same day at 10 a.m. ET. The call will be webcast live on the investor relations section of the company’s website, hudsonrpo.com. The archived call will be available on the investor relations section of the company’s website, hudsonrpo.com. If you wish to join the conference call, please use the dial-in information below:Toll-Free Dial-In Number: (866) 220-5784 International Dial-In Number: (615) 622-8063 Conference ID #: 6893368About...

Continue reading

Amarillo receives final order from Supreme Court of British Columbia for Plan of Arrangement

TORONTO, March 07, 2022 (GLOBE NEWSWIRE) — Amarillo Gold Corporation (the “Company” or “Amarillo”) (TSXV: AGC, OTCQB: AGCBF) has obtained a final order from the Supreme Court of British Columbia approving the previously announced plan of arrangement (the “Arrangement”) under the Business Corporations Act (British Columbia) for the acquisition of Amarillo by Hochschild Mining PLC (“Hochschild”). Under the Arrangement, each share of Amarillo will be exchanged for cash consideration of C$0.40 and one share of Lavras Gold Corp. (“Lavras SpinCo”), a new Brazil-focused exploration company. Information regarding the procedure for exchanging Amarillo shares for the Arrangement consideration is provided in the Company’s management information circular dated January 27, 2022, which is available under the Company’s profile on SEDAR at www.sedar.com...

Continue reading

Brown & Brown, Inc. enters into agreement to acquire Global Risk Partners Limited

DAYTONA BEACH, Fla., March 07, 2022 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), Searchlight and the management ownership team of Global Risk Partners Limited (“GRP”), today announced that the parties have entered into an agreement to acquire the GRP insurance operations. The transaction is expected to close in the third quarter of 2022, subject to certain closing conditions, including the receipt of required regulatory approvals for the Acquisition (including the approval of the Financial Conduct Authority of the United Kingdom). GRP was established in 2013 by Peter Cullum, David Margrett and Stephen Ross. With annual revenue of approximately $340 million, GRP is one of the top independent insurance intermediaries in the United Kingdom (U.K.), servicing nearly...

Continue reading

Viemed Healthcare Announces 2021 Financial Results

LAFAYETTE, La., March 07, 2022 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, today reported its financial results for the three months and year ended December 31, 2021. Operational highlights (all dollar amounts are USD):Net revenues attributable to the Company’s core business for the quarter ended December 31, 2021 were $29.0 million, a new Company record and an increase of 11% over the quarter ended December 31, 2020. Net revenues attributable to the Company’s core business for the quarter ended December 31, 2021 were up approximately 4% over the quarter ended September 30, 2021. Total net revenues for the current...

Continue reading

Inventiva publie ses résultats annuels 2021 : Avancées majeures avec lanifibranor dans la NASH et cedirogant dans le psoriasis

Lancement de l’étude clinique de Phase III NATiV3 avec lanifibranor dans la NASHRéception d’un paiement d’étape de 4 millions d’euros de la part d’AbbVie suite à l’inclusion du premier patient dans l’étude clinique de Phase IIb avec cedirogant1 chez des patients adultes atteints de psoriasis modéré à sévèreLes dépenses de recherche et développement ont doublé pour l’année 2021 à 48,4 millions d’euros par rapport à 2020, principalement en raison de la préparation et du lancement de l’étude clinique de Phase III NATiV3Position de trésorerie2 à 95,4 M€ au 31 décembre 2021 contre 113,0 M€ au 31 décembre 2020Mise en place d’un programme ATM aux Etats-Unis pour la vente d’un montant allant jusqu’à 100 millions de dollars d’ADSDaix (France), Long Island City (New York, Etats-Unis), le 7 mars 2022 – Inventiva (Euronext...

Continue reading

Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and cedirogant in psoriasis

Initiation of the NATiV3 Phase III clinical trial with lanifibranor in NASHReceipt of a €4 m milestone payment from AbbVie following the inclusion of the first patient in the ongoing Phase IIb clinical trial with cedirogant1 in patients with moderate to severe psoriasisR&D expenses doubled for full year 2021 reaching €48.4 m compared to 2020, mainly driven by the preparation and initiation of the NATiV3 Phase III clinical trial Cash position2 at €95.4 m as of December 31, 2021 compared to €113.0 m as of December 31, 2020 Implementation of an At-The-Market (“ATM”) program in the United States for the sale up to $100 m of ADSDaix (France), Long Island City (New York, United States), March 7, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of...

Continue reading

Ranger Oil Announces Fourth Quarter and Full-Year 2021 Results, Shareholder Return Initiatives and 2022 Outlook

— Exceeds Mid-point of Oil Sales Volume Guidance for Q4 2021 —— Targeting $100 Million Share Repurchase Program and Quarterly Dividend — HOUSTON, March 07, 2022 (GLOBE NEWSWIRE) — Ranger Oil Corporation (“Ranger” or the “Company”) (NASDAQ: ROCC) today announced financial and operational results for the fourth quarter and full-year 2021, its near-term plans for shareholder return initiatives through share repurchases and quarterly dividends, and the Company’s 2022 outlook. Significant Highlights Fourth QuarterSold 27,516 barrels of oil per day (“bbl/d”) for the fourth quarter of 2021, exceeding the mid-point of upward revised oil sales guidance. Total sales volumes were 40,236 barrels of oil equivalent per day (“boe/d”); Reported net income of $68 million and adjusted net income(1) of...

Continue reading

Intrepid Reports Fourth Quarter and Full Year 2021 Results

Denver, CO, March 07, 2022 (GLOBE NEWSWIRE) — Intrepid Potash, Inc. (NYSE:IPI) (“Intrepid”, the “Company”, “we”, “us”, “our”) today reports its financial results for the fourth quarter and full year of 2021. Key Fourth Quarter and Full Year 2021 TakeawaysNet income of $223.9 million and $249.8 million in the fourth quarter and full year 2021, respectively, which includes the release of $215.9 million of valuation allowance for deferred tax assets Adjusted net income(1) of $8.0 million and $21.8 million in the fourth quarter and full year 2021, respectively. Recorded $7.0 million of tax expense in the fourth quarter and full-year 2021 as a result of the release of the valuation allowance against the deferred tax assets Adjusted EBITDA(1) of $24.8 million for the fourth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.